Ind-Swift Laboratories informs about disclosure

03 Apr 2024 Evaluate
Ind-Swift Laboratories has attached disclosure received by the Company from Essix Biosciences, as per Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in respect of acquisition of 94,99,720 (Ninety-Four Lakhs Ninety-Nine Thousand Seven Hundred and Twenty) equity shares of Ind-Swift Laboratories by way of inter-se transfer among the promoters.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

107.50 0.35 (0.33%)
23-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1494.95
Dr. Reddys Lab 5882.45
Cipla 1487.45
Zydus Lifesciences 1087.65
Lupin 1631.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.